Fortress Biotech, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2026 Annual Meeting of Stockholders held by Fortress Biotech, Inc. on June 17, 2026. The meeting was conducted virtually and focused on corporate governance matters, specifically the election of directors and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to the results of shareholder votes and does not contain financial performance data.
Material Changes and Voting Results
Two proposals were voted upon by stockholders:
- Proposal 1: Election of Directors Seven directors were elected to serve until the 2027 annual meeting. All seven nominees received a majority of votes cast. Notable vote counts included:
- Lindsay A. Rosenwald, M.D.: 11,022,326 For; 239,772 Against.
- Jimmie Harvey, Jr., M.D.: 10,322,230 For; 923,184 Against.
- J. Jay Lobell: 9,756,949 For; 1,313,658 Against.
- Proposal 2: Ratification of Auditor Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2026.
- Votes For: 23,095,864
- Votes Against: 753,612
- Abstentions: 341,934
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document strictly details the procedural outcomes of the annual meeting.
Key Facts for Investor Verification
- Verify the full list of elected directors and their tenure terms in the definitive proxy statement (Schedule 14A) filed on April 28, 2026.
- Confirm the total number of shares outstanding and voting rights to contextualize the vote totals provided.
- Review the Schedule 14A for detailed biographies of the directors and the rationale for the auditor selection.
- Note that this filing contains no financial performance updates; refer to the most recent 10-Q or 10-K for financial metrics.